Advances in BRAF-targeted therapies for non-small cell lung cancer: the promise of encorafenib and binimetinib

被引:1
|
作者
Fareed, Areeba [1 ]
Amir, Nabiha [1 ]
Ajaz, Humna [2 ]
Sohail, Afra [1 ]
Vaid, Rayyan [1 ]
Farhat, Solay [3 ]
机构
[1] Karachi Med & Dent Coll, Dept Med, Karachi, Pakistan
[2] Jinnah Sindh Med Univ, Karachi, Pakistan
[3] Lebanese Univ, Fac Med Sci, Beirut, Lebanon
关键词
OPEN-LABEL; DABRAFENIB;
D O I
10.1097/JS9.0000000000001051
中图分类号
R61 [外科手术学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:1891 / 1893
页数:3
相关论文
共 50 条
  • [21] Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in context
    Le, Alexander D.
    Alzghari, Saeed K.
    Jean, Gary W.
    La-Beck, Ninh M.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 223 - 236
  • [22] Recent advances in non-small cell lung cancer targeted therapy; an update review
    Araghi, Mahmood
    Mannani, Reza
    Maleki, Ali Heidarnejad
    Hamidi, Adel
    Rostami, Samaneh
    Safa, Salar Hozhabri
    Faramarzi, Fatemeh
    Khorasani, Sahar
    Alimohammadi, Mina
    Tahmasebi, Safa
    Akhavan-Sigari, Reza
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [23] BRAF inhibitors in metastatic non-small cell lung cancer
    Anguera, Georgia
    Majem, Margarita
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 589 - 592
  • [24] Targeted treatment of non-small cell lung cancer
    Scheffler, Matthias
    Michels, Sebastian
    Nogova, Lucia
    INNERE MEDIZIN, 2022, 63 (07): : 700 - 708
  • [25] Targeted Therapy for Non-Small Cell Lung Cancer
    Jett, James R.
    Carr, Laurie L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (08) : 907 - 912
  • [26] Targeted Therapy for Non-Small Cell Lung Cancer
    Noor, Zorawar S.
    Cummings, Amy L.
    Johnson, McKenna M.
    Spiegel, Marshall L.
    Goldman, Jonathan W.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (03) : 409 - 434
  • [27] Targeted therapy for non-small cell lung cancer
    Glanemann, Franziska
    Wiesweg, Marcel
    ONKOLOGIE, 2024, 30 (09): : 877 - 885
  • [28] Dual inhibition of BRAF and MEK in BRAF-mutated metastatic non-small cell lung cancer
    Kim, Young Hak
    JOURNAL OF THORACIC DISEASE, 2016, 8 (09) : 2369 - 2371
  • [29] The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer
    Melosky, Barbara
    Wheatley-Price, Paul
    Juergens, Rosalyn A.
    Sacher, Adrian
    Leighl, Natasha B.
    Tsao, Ming-Sound
    Cheema, Parneet
    Snow, Stephanie
    Liu, Geoffrey
    Card, Paul B.
    Chu, Quincy
    LUNG CANCER, 2021, 160 : 136 - 151
  • [30] New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer
    Genova, Carlo
    Rijavec, Erika
    Biello, Federica
    Rossi, Giovanni
    Barletta, Giulia
    Dal Bello, Maria Giovanna
    Vanni, Irene
    Coco, Simona
    Alama, Angela
    Grossi, Francesco
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (01) : 19 - 33